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From February 1, 2000, to December 4, 2001, a total of 119
bats (85 Megachiroptera and 34 Microchiroptera) were tested
for Australian bat lyssavirus (ABLV) infection. Eight Megachi-
roptera were positive by immunofluorescence assay that used
cross-reactive antibodies to rabies nucleocapsid protein. A
case study of cross-species transmission of ABLV supports the
conclusion that a bat reservoir exists for ABLV in which the
virus circulates across Megachiroptera species within mixed
communities.
ince the identification of Australian bat lyssavirus
(ABLV) in bat species throughout Australia (1), public
health units have been forced to confront its implications for
human health. Fortunately, because of the close genetic and
serologic relationship between rabies and ABLV, rabies
immune sera and vaccines offer postexposure protection from
infection (1,2). A bite or scratch from a bat in Australia consti-
tutes a potential exposure to ABLV, and persons affected
should be offered postexposure prophylaxis unless the bat can
be shown to be uninfected with ABLV. However, such prophy-
laxis is costly and uncomfortable, and immune sera are in
short supply worldwide. As many bats involved in such inci-
dents are uninfected, and a negative results obviates the need
for postexposure prophylaxis, determining each bat’s ABLV
infection status is preferable. Under instruction from the pub-
lic health units, Queensland Health Scientific Services Public
Health Virology Laboratory has tested bats for ABLV since
July 1998.
Two strains of ABLV are known to be circulating. One
strain was isolated from a species of insectivorous Microchi-
roptera, Saccolaimus flaviventris (1). A second strain has been
shown to infect the four species of Megachiroptera in the
genus Pteropus that occur in mainland Australia (1,3). Isolates
from the four pteropid species show minimal sequence varia-
tion with geographic origin and species and are essentially
identical (I.L. Smith, unpub. data). Pteropid bats are nomadic
nocturnal mammals that roost in trees during the day in colo-
nies that frequently number in the thousands. Colonies may
contain one or more species, and fluctuate in size, depending
on available food resource (4). This dynamic social structure
has been evoked to explain the circulation of a single strain of
ABLV in pteropids (1).
In this article, we report on surveillance of bats brought in
for testing to our laboratory. A case is described in which cir-
cumstantial evidence exists for bat-to-bat cross-species trans-
mission of ABLV. This finding is consistent with a model in
which the social structure of pteropid camps results in a single
strain of circulating virus.
The Study
Bats involved in incidents involving public health were
tested for ABLV infection by immunofluorescence assay (IFA)
on brain impression smears by using a fluorescein isothiocyan-
ate-conjugated monoclonal (Fujirebio Diagnostics, Malvern,
PA) or polyclonal (Biorad, Hercules, CA) antibodies to the
nucleocapsid protein. The IFA was performed in parallel with
a fluorescent real-time polymerase chain reaction (PCR) assay
(5) for pteropid samples, or a heminested reverse transcriptase
(RT)-PCR for all others (6). When it was possible, the bat was
identified to the species level (7). For molecular analyses, the
region encoding the carboxy-terminal of the glycoprotein and
its long 3′  untranslated region were amplified by RT-PCR, and
the products were directly sequenced by using Big-Dye chem-
istry (Applied Biosystems, Foster City, CA). Primers and reac-
tion details are available on request.
During February 1, 2000, to December 4, 2001, a total of
119 bats, including 85 Megachiroptera  and 34 Microchi-
roptera, were submitted for testing to the Public Health Virol-
ogy Laboratory, Queensland Health Scientific Services. Bats
submitted for testing had either bitten or scratched a person, or
testing was considered to be in the interests of public health.
Eight bats tested positive for ABLV infection by IFA (Table 1).
Six of the bats positive for ABLV were P. alecto (75%); one
bat positive for ABLV was P. poliocephalus (12.5%), and
another bat that tested positive was an unidentified member of
the genus Pteropus  (12.5%). No positive Microchiroptera
were obtained during the study period. Positive bats were from
the Rockhampton area (37.5%), south of the Brisbane South
metropolitan area (25%), Townsville area (12.5%), Sunshine
Coast area (12.5%), and Brisbane South Coast area (12.5%).
Confirmatory real-time or heminested RT-PCR results were
concordant with IFA in all cases. Controls for contamination
were negative for ABLV. 
In October 2000, a wild Black Flying Fox (bat 1, P. alecto)
that was acting aggressively was removed from the top of a
dome-shaped wire-mesh enclosure for viewing bats at a zoo in
Rockhampton. Inside this enclosure were housed 23 flying
foxes, all previously well. No new bats had been added to the
*Queensland Health Scientific Services, Archerfield, Queensland, Aus-
tralia; †Queensland Department of Primary Industries, Moorooka,
Queensland, Australia; ‡Public Health Services, Rockhampton,
Queensland, Australia; and §Queensland Parks and Wildlife Service,
Rockhampton, Queensland, Australia
SEmerging Infectious Diseases  •  Vol. 9, No. 2, February 2003 263
DISPATCHES
cage for 12 months. The animal was euthanized and sent for
testing to Queensland Health Scientific Services where it
tested positive for ABLV by IFA on brain impression smear.
One month later a captive Gray-headed Flying Fox (bat 2, P.
poliocephalus) from within the enclosure was observed behav-
ing abnormally. Normally a highly social animal, the bat was
not moving freely and was licking its vulva profusely. The ani-
mal was relocated to an isolation cage where, during the next
20 hours, it exhibited a progressive neurologic syndrome. The
bat was euthanized and found to be positive for ABLV by IFA. 
To enable molecular epidemiologic studies to be carried
out, the genomic RNA extracted from the brain of the two fly-
ing foxes mentioned previously, from another three other fly-
ing foxes from disparate locations (two Black Flying Foxes
and one Little Red Flying Fox [P. scapulatus]), and from a per-
son who acquired a fatal infection attributed to a flying fox
were amplified across the variable noncoding intergenic
region between the glycoprotein and polymerase. The reaction
products were directly sequenced, and the differences are pre-
sented in Table 2. Of the six differences among the sequenced
isolates, five were unique to both bats 1 and 2 submitted by the
zoo. To date, ABLV sequence variation in flying foxes has
been minimal across location, species, and time (I.L. Smith,
unpub. data), so the identical variation seen in these two bats
supports a model of natural cross-species bat-to-bat transmis-
sion. 
The remaining captive bats in the enclosure were quaran-
tined in a private facility off-site and were closely monitored
for clinical, serologic, and behavioral changes during the next
3 months, and then for a further 3 months after they returned to
their original enclosure. No attributable clinical disease, sero-
conversion, or behavioral change was observed during this
time. The bat enclosure was modified to incorporate an extra
outer mesh layer to prevent future direct contact with free-liv-
ing wild bats outside the enclosure. Existing double-fencing
had already prevented the public from having direct contact
with flying foxes in the enclosure.
Conclusions
The infection prevalence of 9.4% in submitted flying foxes
in this study is not statistically significantly higher than that
previously observed (6%) in sick, injured, and orphan flying
fox submissions (3; H.E. Field, unpub.data); the wide 95%
confidence interval (CI) (4% to 18%) reflects the limited sam-
ple size in this study. The prevalence is, however, statistically
significantly higher than that observed in wild-caught flying
foxes (3; H.E. Field, unpub. data), reinforcing the contention
that the subpopulation of sick and injured flying foxes poses a
higher risk for exposed humans. None of the submitted Micro-
chiroptera was positive for ABLV. The small sample size in
this study limits meaningful interpretation of this observation
(the 95% CI for 0% prevalence with a sample size of 34 is 0%
to 10%). Although this finding could indicate a lower inci-
dence of ABLV in communities of Microchiroptera, down-
playing the risk for human exposure posed by Microchiroptera
in Australia would be premature.
The incident showing transmission from an ABLV-
infected wild flying fox to a captive flying fox is interesting in
two respects. First, an incubation period for the virus can be
estimated. Assuming the scratch/bite occurred close to the
time when the wild bat was discovered, the captive bat was
observed to display symptoms after 29 days. This period com-
pares with the only reported incubation time for an ABLV
infection in a Black Flying Fox (P. alecto) of 6–9 weeks (9).
Incubation times after experimental infection of Vampire Bats
with rabies were shorter at 7–26 days for intramuscular injec-
tion (10) or 2–4 weeks after subcutaneous or intramuscular
injection (11).
Second, this report is the first to describe probable natural
cross-species transmission. This finding has implications for
Table 1. Bats positive for Australian bat lyssavirus infection
Species IFA positivea
Megachiroptera
Pteropodidae
Pteropus alecto 6/50
Pteropus scapulatus 0/18
Pteropus poliocephalus 1/8
Pteropus conspicillatus 0/4
Unidentified Pteropus 1/5
Subtotal 8/85
Microchiroptera
Hipposideridae
Hipposiderosater 0/1
Molossidae
Mormopterus beccarii 0/2
Mormopterus loriae 0/2
Unidentified Mormopterus 0/2
Rhinolophidae
Rhinolophus philippinensis 0/1
Vespertilionidae
Chalinolobus gouldii 0/1
Miniopterus australis 0/3
Miniopterus schreibersii 0/1
Miniopterus scotorepens 0/1
Scotorepens orion 0/1
Unidentified Scotorepens  0/1
Unidentified Vespertilionidae 0/14
Unidentified Microchiroptera 0/4
Subtotal 0/34
Total 8/119
aIFA, immunofluorescence assay; number positive/number tested.DISPATCHES
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our understanding of how the virus circulates in bat communi-
ties. Evidence of cross-species transmission is consistent with
the minimal sequence variation in isolates from sick or injured
flying foxes obtained from various species at different sites
around Australia (1). The large seasonally nomadic, multispe-
cies colonies in which flying foxes commonly congregate (and
interact) provide opportunity for interspecies and interregion
transmission of ABLV. Our findings support this model for cir-
culation of ABLV in pteropid colonies. 
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Table 2. Nucleotide differences in the glycoprotein coding/noncoding region of Australian bat lyssavirus (ABLV)
Nucleotidea
Isolate host 4701 4751 4899 4987 5037 5058
Pteropus alectob AGGC G A
Pteropus poliocephalusc AGGC G A
Pteropus alectod CAAT A G
Pteropus alectod CAGT A G
Pteropus scapulatusd CAGT A G
Humand CAGT A G
Pteropus alectoe CAGT A G
aNucleotide position from the Ballina isolate of the pteropid strain of ABLV (8); A, deoxyadenosine; C, deoxcytidine; G, deoxyguanosine; T, thymidine.
bCase study, bat 1.
cCase study, bat 2.
dQueensland Health Scientific Services collection.
eFrom reference 8.